December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Top Electronic Document Management Systems for Pharmaceutical Industry Compliance and Digital Quality Transformation ↗
Via Talk Markets
Exposures Product Safety
News headline image
Ibogaine by David Dardashti Announces Initiative to Educate Policymakers on Advanced Safety Protocols Amid Historic Federal Policy
Via AB Newswire
Topics Economy
Exposures Product Safety Supply Chain
News headline image
AI Stock Analyst: Financial News API & Monitoring Tool for Investors Announced
Via Press Release Distribution Service
Topics Artificial Intelligence Lawsuit
Exposures Artificial Intelligence Financial Legal
News headline image
Here's Exactly How Stellantis Can Make Investors Big Winners ↗
Via The Motley Fool
Topics Product Recall
Tickers F GM STLA TM
Exposures Legal Product Safety
News headline image
FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant
Via Investor Brand Network
Tickers RGNT
Exposures Product Safety
News headline image
Latest VIP Number Plate Price List Across India ↗
Via Talk Markets
Topics Product Recall
Exposures Legal Product Safety
News headline image
Marine Toys for Tots Foster Care Program Creates Room for Joy for Children in Foster Care This National Foster Care Month
Via Get News
Topics Product Recall
Exposures Legal Product Safety
News headline image
First Commercial Deployment of FDA-Cleared Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder and Other Neurological Conditions: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Government
Tickers NRXP
Exposures Political Product Safety
News headline image
What Makes a Bag Truly Cut-Proof? Materials and Structure Explained
Via AB Newswire
Topics Product Recall
Tickers AMZN
Exposures Legal Product Safety
News headline image
Discreet Nicotine Vaping Devices For Low-Profile Use: Product Guide Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
PDSB Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
Tickers PDSB
Exposures Financial Intellectual Property Product Safety
News headline image
Gossamer Bio (GOSS) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Tickers GOSS
Exposures Product Safety
News headline image
NRx (NRXP) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers NRXP
Exposures Financial Product Safety
News headline image
MediWound (MDWD) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Tickers MDWD VCEL
Exposures Product Safety
News headline image
Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
Via PRLog
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
Regentis Biomaterials Ltd. (NYSE American: RGNT) Is ‘One to Watch’
Via Investor Brand Network
Tickers RGNT
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Phase 1 TNX-1500 Data Supporting Advancement into Phase 2
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
News headline image
EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND Submission ↗
Via Benzinga
Exposures Product Safety
News headline image
Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances ↗
Via MarketBeat
Tickers LYEL
Exposures Product Safety
News headline image
IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit ↗
Via MarketBeat
Tickers ARM IDYA
Exposures Product Safety
News headline image
Why Novavax (NVAX) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Economy
Tickers NVAX
Exposures Artificial Intelligence COVID-19 Interest Rates
News headline image
Outlook Shares Jump Following FDA Appeal Decision For LYTENAVA ↗
Via Benzinga
Exposures Product Safety
News headline image
Are Wall Street Analysts Bullish on Charles River Laboratories Stock?
Via Barchart.com
Topics ETFs Stocks
Tickers MS
Exposures Product Safety US Equities
News headline image
Peptide Therapy Websites Tout Benefits Nearly 4x More Often Than Safety Details, 100-Page Audit Finds
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus ↗
Via MarketBeat
Tickers KPTI
Exposures Product Safety
News headline image
Ontdek verborgen details over Retatrutide Kopen ↗
Via Talk Markets
Exposures Product Safety
News headline image
Stay Safe at Home: Expert Tips From Building Safety Professionals
Via StatePoint Media
Topics Product Recall
Exposures Legal Product Safety
News headline image
Full size steam table pans – deep/medium/shallow trays + foil lids
Via AB Newswire
Tickers AMZN
Exposures Product Safety
News headline image
Don't Buy Viking Therapeutics Stock Until You Read This ↗
Via The Motley Fool
Tickers LLY NVO VKTX
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.